Security key
M74240108
NeuroSense Therapeutics Ltd. - ORDINARY SHARES (NRSN)
CUSIP: M74240108
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / ORDINARY SHARES
- Total 13F shares
- 277,925
- Total 13F value
- $346,797
- Share change
- -225,319
- SEC-reported price per share
- $1.25
- Number of holders
- 10
- Value change
- -$459,778
- Number of buys
- 3
- Number of sells
- 10
Report period
Q3 2025
Institutions
10
Top holders
10
NRSN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
NeuroSense Therapeutics Ltd. SEC filings
NeuroSense Therapeutics Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M74240108
Recent filing periods:
Ownership snapshot
Top reported holders of NRSN - NeuroSense Therapeutics Ltd. - ORDINARY SHARES (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CITADEL ADVISORS LLC
Disclosed value leader
CITADEL ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Jun 2025
13F
Highest disclosed value: $282,069
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
CITADEL ADVISORS LLC has the largest disclosed position value at $282.1K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens CITADEL ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
CITADEL ADVISORS LLC
$282.1K
MORGAN STANLEY
$151K
Yorkville Advisors Global, LP
$113.4K
Squarepoint Ops LLC
$94.4K
MEITAV INVESTMENT HOUSE LTD
$75.6K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$282,069
149,243 shares
|
— | 30 Jun 2025 |
| MORGAN STANLEY |
13F
Company
|
—
class O/S missing
|
$151,011
79,900 shares
|
— | 30 Jun 2025 |
| Yorkville Advisors Global, LP |
13F
Company
|
—
class O/S missing
|
$113,400
60,000 shares
|
— | 30 Jun 2025 |
| Squarepoint Ops LLC |
13F
Company
|
—
class O/S missing
|
$94,358
49,925 shares
|
— | 30 Jun 2025 |
| MEITAV INVESTMENT HOUSE LTD |
13F
Company
|
—
class O/S missing
|
$75,600
40,000 shares
|
— | 30 Jun 2025 |
| JANE STREET GROUP, LLC |
13F
Company
|
—
class O/S missing
|
$54,222
28,689 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
277,925
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
17
Q3 2025 holders
10
Holder diff
-7
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend